Ibrahim Demirci
Overview
Explore the profile of Ibrahim Demirci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okur S, Eksi H, Demirci I, Eksi F
Psychol Rep
. 2023 Jun;
:332941231181302.
PMID: 37265225
Academic encouragement provides opportunities for individuals to achieve their educational objectives and influences both academic satisfaction and academic self-efficacy of individuals. In this study, academic self-efficacy and academic satisfaction constitute...
2.
Sonmez A, Demirci I, Haymana C, Tasci I, Ayvali M, Ata N, et al.
Atherosclerosis
. 2023 May;
375:9-20.
PMID: 37216728
Background And Aims: Familial hypercholesterolemia (FH) is the most common cause of premature atherosclerotic cardiovascular disease (ASCVD). Türkiye is among the countries with the highest rate of ASCVD. However, no...
3.
Batman A, Yazici D, Dikbas O, Agbaht K, Saygili E, Demirci I, et al.
J Clin Endocrinol Metab
. 2023 May;
108(10):e1013-e1026.
PMID: 37186260
Context: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism. Methods:...
4.
Demirci I, Haymana C, Candemir B, Yuksel B, Eser M, Meric C, et al.
Arch Endocrinol Metab
. 2023 Apr;
67(3):378-384.
PMID: 37011373
Objective: This study aimed to investigate the triglyceride-glucose (TyG) index, which is a simple surrogate marker of insulin resistance that is associated with various cardiometabolic diseases, in patients with Klinefelter...
5.
Sonmez A, Haymana C, Demirci I, Cesur M, Rizzo M, Tasci I
Int J Cardiol Cardiovasc Risk Prev
. 2022 Dec;
15:200160.
PMID: 36573189
Background: The prevalence of diabetes mellitus is growing worldwide, showing almost a 10-fold increase in the last five decades. Despite advances in the understanding of the disease mechanisms, preventive measures,...
6.
Aydogan U, Doganer Y, Haymana C, Kaplan U, Aydogdu A, Demirci I, et al.
Arch Endocrinol Metab
. 2022 Dec;
67(2):179-188.
PMID: 36468923
Objective: This study aimed to investigate the frequency of sexual dysfunction and the effect of short-term testosterone replacement therapy on sexual functions in congenital hypogonadism patients. Furthermore, we sought to...
7.
Sahin M, Demirci I, Haymana C, Tasci I, Emral R, Cakal E, et al.
Horm Metab Res
. 2022 Nov;
55(1):25-30.
PMID: 36328149
To which extent the pre-existing hypothyroidism or hyperthyroidism has an impact on coronavirus infection 2019 (COVID-19) outcomes remains unclear. The objective of this study was to evaluate COVID-19 morbidity and...
8.
Demirci I, Haymana C, Tasci I, Satman I, Atmaca A, Sahin M, et al.
Endokrynol Pol
. 2022 Feb;
73(1):87-95.
PMID: 35119089
Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 diabetes (T2DM)...
9.
Demirci I, Haymana C, Salman S, Tasci I, Corapcioglu D, Kirik A, et al.
World J Diabetes
. 2022 Jan;
12(12):2107-2118.
PMID: 35047124
Background: Vaccination against influenza and pneumococcus is effective in reducing morbidity and mortality in patients with diabetes. Aim: To investigate the prevalence of influenza and pneumococcal vaccinations and to search...
10.
Sahin M, Demirci I, Haymana C, Tasci I, Sonmez A
Clin Endocrinol (Oxf)
. 2021 Dec;
99(6):533-534.
PMID: 34967024
No abstract available.